Great West Life Assurance CO Allogene Therapeutics, Inc. Transaction History
Great West Life Assurance CO
- $53.1 Billion
- Q2 2024
A detailed history of Great West Life Assurance CO transactions in Allogene Therapeutics, Inc. stock. As of the latest transaction made, Great West Life Assurance CO holds 24,092 shares of ALLO stock, worth $71,312. This represents 0.0% of its overall portfolio holdings.
Number of Shares
24,092
Previous 17,750
35.73%
Holding current value
$71,312
Previous $79,000
29.11%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding ALLO
# of Institutions
176Shares Held
132MCall Options Held
94.3KPut Options Held
112K-
Tpg Gp A, LLC Fort Worth, TX18.7MShares$55.4 Million1.08% of portfolio
-
Black Rock Inc. New York, NY16.4MShares$48.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.2MShares$24.3 Million0.0% of portfolio
-
State Street Corp Boston, MA7.67MShares$22.7 Million0.0% of portfolio
-
Capital World Investors Los Angeles, CA6.9MShares$20.4 Million0.0% of portfolio
About Allogene Therapeutics, Inc.
- Ticker ALLO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 143,807,008
- Market Cap $426M
- Description
- Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...